Table 1. Participants demography.
AD | iNPH | Controls | |
---|---|---|---|
Patients, N (males—females) | 36 (12–24) | 32 (19–13) | 12 (9–3) |
Median Age, years (min-max) | 77 (68–86) | 83.5 (70–91) | 75.5 (55–84) |
Median CSF Aβ, pg/mL (min-max) | 467 (226–1151) | 747 (250–1570) | 1062 (453–1515) |
Median CSF Tau, pg/mL (min-max) | 573.5 (110–2952) | 159 (46–676) | 95 (49–149) |
Median CSF p-Tau, pg/mL (min-max) | 72 (18–475) | 29 (15–73) | 29 (7–37) |